Table 2. Subgroup analysis APC promoter methylation in breast cancer.
Case | Control | OR [95% CI] | P | I2 (%) | Model | |||
---|---|---|---|---|---|---|---|---|
M | UM | M | UM | |||||
Total | 815 | 1258 | 147 | 1017 | 5.92 [3.16, 11.07] | < 0.00001 | 77 | Random |
Method | ||||||||
MSP | 318 | 320 | 33 | 316 | 13.38 [4.34, 41.25] | < 0.00001 | 72 | Random |
QMSP | 497 | 938 | 114 | 728 | 3.11 [1.72, 5.62] | 0.0002 | 65 | Random |
Ethnicity | ||||||||
Caucasian | 591 | 941 | 133 | 589 | 3.08 [1.92, 4.96] | < 0.00001 | 52 | Random |
non-Caucasian | 224 | 317 | 14 | 428 | 18.75 [4.12, 85.28] | < 0.0001 | 75 | Random |
Control type | ||||||||
Blood | 231 | 667 | 32 | 495 | 7.42 [1.55, 35.48] | 0.01 | 89 | Random |
Tissue | 584 | 600 | 115 | 522 | 4.56 [2.63, 7.90] | < 0.00001 | 52 | Random |
M, methylation; UM unmethylation; MSP, Methylation-Specific PCR; QMSP, Quantitative real time Methylation Specific.